T. Rowe Price Associates’s Chimerix, Inc. CMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-67,265
| Closed | -$573K | – | 3173 |
|
|
2025
Q1 | $573K | Buy |
+67,265
| New | +$371K | ﹤0.01% | 2201 |
|
|
2023
Q2 | – | Sell |
-15,175
| Closed | -$20K | – | 2966 |
|
|
2023
Q1 | $20K | Buy |
15,175
+896
| +6% | +$1.46K | ﹤0.01% | 2861 |
|
|
2022
Q4 | $27K | Hold |
14,279
| – | – | ﹤0.01% | 2864 |
|
|
2022
Q3 | $28K | Buy |
+14,279
| New | +$32K | ﹤0.01% | 2895 |
|
|
2021
Q3 | – | Sell |
-1,632,612
| Closed | -$13.1M | – | 2995 |
|
|
2021
Q2 | $13.1M | Sell |
1,632,612
-106,257
| -6% | -$884K | ﹤0.01% | 1381 |
|
|
2021
Q1 | $16.8M | Buy |
+1,738,869
| New | +$16M | ﹤0.01% | 1313 |
|
|
2019
Q4 | – | Sell |
-21,121
| Closed | -$50K | – | 2556 |
|
|
2019
Q3 | $50K | Buy |
21,121
+216
| +1% | +$624 | ﹤0.01% | 2488 |
|
|
2019
Q2 | $90K | Sell |
20,905
-119,107
| -85% | -$366K | ﹤0.01% | 2490 |
|
|
2019
Q1 | $294K | Buy |
140,012
+100
| +0.1% | +$228 | ﹤0.01% | 2302 |
|
|
2018
Q4 | $360K | Buy |
139,912
+87
| +0.1% | +$291 | ﹤0.01% | 2213 |
|
|
2018
Q3 | $544K | Buy |
139,825
+255
| +0.2% | +$1.09K | ﹤0.01% | 2122 |
|
|
2018
Q2 | $664K | Buy |
139,570
+52
| +0% | +$249 | ﹤0.01% | 2017 |
|
|
2018
Q1 | $725K | Buy |
139,518
+91
| +0.1% | +$461 | ﹤0.01% | 1930 |
|
|
2017
Q4 | $646K | Hold |
139,427
| – | – | ﹤0.01% | 1986 |
|
|
2017
Q3 | $732K | Hold |
139,427
| – | – | ﹤0.01% | 1924 |
|
|
2017
Q2 | $760K | Hold |
139,427
| – | – | ﹤0.01% | 1893 |
|
|
2017
Q1 | $890K | Hold |
139,427
| – | – | ﹤0.01% | 1834 |
|
|
2016
Q4 | $641K | Sell |
139,427
-20,871
| -13% | -$98.5K | ﹤0.01% | 1951 |
|
|
2016
Q3 | $888K | Hold |
160,298
| – | – | ﹤0.01% | 1787 |
|
|
2016
Q2 | $630K | Buy |
160,298
+100
| +0.1% | +$494 | ﹤0.01% | 1876 |
|
|
2016
Q1 | $819K | Hold |
160,198
| – | – | ﹤0.01% | 1775 |
|
|
2015
Q4 | $1.43M | Sell |
160,198
-2,767,957
| -95% | -$99.7M | ﹤0.01% | 1598 |
|
|
2015
Q3 | $112M | Sell |
2,928,155
-77,267
| -3% | -$3.82M | 0.02% | 541 |
|
|
2015
Q2 | $139M | Buy |
3,005,422
+147,458
| +5% | +$5.91M | 0.03% | 520 |
|
|
2015
Q1 | $108M | Buy |
2,857,964
+440,702
| +18% | +$17.5M | 0.02% | 587 |
|
|
2014
Q4 | $97.3M | Sell |
2,417,262
-23,255
| -1% | -$788K | 0.02% | 628 |
|
|
2014
Q3 | $67.4M | Buy |
2,440,517
+38,237
| +2% | +$928K | 0.01% | 722 |
|
|
2014
Q2 | $52.7M | Buy |
2,402,280
+1,174,719
| +96% | +$23.3M | 0.01% | 852 |
|
|
2014
Q1 | $28M | Buy |
1,227,561
+309,861
| +34% | +$6.25M | 0.01% | 1023 |
|
|
2013
Q4 | $13.9M | Buy |
917,700
+170,300
| +23% | +$2.72M | ﹤0.01% | 1198 |
|
|
2013
Q3 | $16.4M | Sell |
747,400
-33,400
| -4% | -$687K | ﹤0.01% | 1142 |
|
|
2013
Q2 | $18.9M | Buy |
+780,800
| New | +$16.3M | 0.01% | 1078 |
|
Other funds holding CMRX
T. Rowe Price Associates's CMRX Position: Q2 2025 in Review
T. Rowe Price Associates sold out of Chimerix, Inc. (CMRX) in Q2 2025, closing a stake of 67,265 shares — an estimated $573K sold.
T. Rowe Price Associates first reported a position in CMRX in Q2 2013 and held it in 32 quarters. The position peaked at $139M in Q2 2015. 1 fund tracked by Wall St. Rank holds CMRX as of Q2 2025.
- T. Rowe Price Associates reported no remaining Chimerix, Inc. position as of Q2 2025 after selling out during the quarter.
- T. Rowe Price Associates sold 67,265 Chimerix, Inc. shares in Q2 2025, an estimated $573K.
- T. Rowe Price Associates first reported a position in Chimerix, Inc. in Q2 2013 and held it in 32 quarters.
- T. Rowe Price Associates's Chimerix, Inc. position peaked at $139M in Q2 2015.
- 1 fund tracked by Wall St. Rank held Chimerix, Inc. as of Q2 2025.
Based on T. Rowe Price Associates's 13F filing for Q2 2025, filed 14 Aug 2025.